REGENXBIO-Regenxbio (RGNX) Q1 Earnings and Revenues Lag Estimates

Regenxbio (RGNX) came out with quarterly earnings of $0.12 per share, missing the Zacks Consensus Estimate of$ 0.41 per share. This compares to loss of $1.38 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -70.73%. A quarter ago, it was expected that this biotechnology company would post a loss of$ 1.27 per share when it actually produced a loss of $1.01, delivering a surprise of 20.47%.Over the last four quarters, the company ...